Sökning: WFRF:(Karlqvist Sara 1992 ) >
Long-term outcomes ...
-
Visuri, Isabella,1991-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Orebro Univ, Sweden
(författare)
Long-term outcomes of vedolizumab in inflammatory bowel disease : the Swedish prospective multicentre SVEAH extension study
- Artikel/kapitelEngelska2023
Förlag, utgivningsår, omfång ...
-
Sage Publications,2023
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:oru-106367
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-106367URI
-
https://doi.org/10.1177/17562848231174953DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:153282379URI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-196910URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Funding agencies:Takeda Pharmaceutical Company Ltd EUPAS22735Swedish government's agreement on medical training and research OLL-836791 OLL-934569 OLL-929900 OLL-960775
-
Funding Agencies|Takeda [EUPAS22735]; Swedish governments agreement on medical training and research [OLL-836791, OLL-934569, OLL-929900, OLL-960775]
-
BACKGROUND: Real-world data on long-term outcomes of vedolizumab (VDZ) are scarce.OBJECTIVE: To assess long-term outcomes (up to 3 years) of VDZ in treating inflammatory bowel disease (IBD).DESIGN: A nationwide, prospective multicentre extension of a Swedish observational study on VDZ assessing Effectiveness And Healthcare resource utilization in patients with IBD (SVEAH).METHODS: After re-consent, data of patients with Crohn's disease (CD) (n = 68) and ulcerative colitis (UC) (n = 46) treated with VDZ were prospectively recorded using an electronic case report form integrated with the Swedish IBD Register (SWIBREG). The primary outcome was clinical remission (defined as Harvey-Bradshaw Index ⩽4 in CD and partial Mayo score ⩽2 in UC) at 104 and 156 weeks in patients with a response and/or remission 12 weeks after starting VDZ. Secondary outcomes included health-related quality of life (HRQoL) and biochemical outcomes.RESULTS: VDZ continuation rates were high at weeks 104 and 156, 88% and 84%, respectively, for CD and 87% and 78%, respectively, for UC. Of the 53 CD patients with a response/remission at 12 weeks, 40 (75%) patients were in remission at 104 weeks and 42 (79%) patients at 156 weeks. For UC, these numbers were 25/31 (81%) and 22/31 (71%), respectively. Improvements were seen in the Short Health Scale (p < 0.01 for each dimension; CD, n = 51; UC, n = 33) and the EuroQol 5-Dimensions, 5-levels index value (p < 0.01; CD, n = 39; UC, n = 30). Median plasma-C-reactive protein concentrations (mg/L) decreased from 5 at baseline to 4 in CD (p = 0.01, n = 53) and from 5 to 4 in UC (p = 0.03, n = 34) at 156 weeks. Correspondingly, median faecal-calprotectin (µg/g) decreased from 641 to 114 in CD patients (p < 0.01, n = 26) and from 387 to 37 in UC patients (p = 0.02, n = 17).CONCLUSION: VDZ demonstrated high continuation rates and was associated with improvements in clinical outcomes, HRQoL measures and inflammatory markers at 2 and 3 years after treatment initiation in this prospective national SVEAH extension study.REGISTRATION: ENCePP registration number: EUPAS22735.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Eriksson, Carl,1981-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden,Orebro Univ, Sweden; Karolinska Inst, Sweden(Swepub:oru)clen
(författare)
-
Karlqvist, Sara,1992-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Orebro Univ, Sweden(Swepub:oru)srt
(författare)
-
Lykiardopoulos, ByronLinköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Mag- tarmmedicinska kliniken(Swepub:liu)byrly66
(författare)
-
Karlén, PerDepartment of Internal Medicine, Danderyd Hospital, Stockholm, Sweden,Danderyd Hosp, Sweden
(författare)
-
Grip, OlofDepartment of Gastroenterology, Skåne University Hospital, Malmö/Lund, Sweden,Skane Univ Hosp, Sweden
(författare)
-
Söderman, CharlotteKarolinska Institutet,St Goran Hosp, Sweden
(författare)
-
Almer, SvenKarolinska Institutet,Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden
(författare)
-
Hertervig, ErikDepartment of Gastroenterology, Skåne University Hospital, Malmö/Lund, Sweden,Skane Univ Hosp, Sweden
(författare)
-
Marsal, JanDepartment of Gastroenterology, Skåne University Hospital, Malmö/Lund, Sweden,Skane Univ Hosp, Sweden
(författare)
-
Malmgren, CarolinaTakeda Pharma AB, Stockholm, Sweden
(författare)
-
Delin, JennyDepartment of Gastroenterology, Ersta Hospital, Stockholm, Sweden,Ersta Hosp, Sweden
(författare)
-
Strid, HansDepartment of Internal Medicine, Södra Älvsborgs Hospital, Borås, Sweden,Sodra Alvsborgs Hosp, Sweden
(författare)
-
Sjöberg, MatsDepartment of Internal Medicine, Skaraborgs Hospital, Lidköping, Sweden,Skaraborgs Hosp, Sweden
(författare)
-
Bergemalm, DanielDepartment of Gastroenterology,Orebro Univ, Sweden
(författare)
-
Hjortswang, HenrikLinköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Mag- tarmmedicinska kliniken(Swepub:liu)henhj44
(författare)
-
Halfvarson, Jonas,1970-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Orebro Univ, Sweden(Swepub:oru)jshn
(författare)
-
Örebro universitetInstitutionen för medicinska vetenskaper
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Therapeutic Advances in Gastroenterology: Sage Publications161756-283X1756-2848
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Visuri, Isabella ...
-
Eriksson, Carl, ...
-
Karlqvist, Sara, ...
-
Lykiardopoulos, ...
-
Karlén, Per
-
Grip, Olof
-
visa fler...
-
Söderman, Charlo ...
-
Almer, Sven
-
Hertervig, Erik
-
Marsal, Jan
-
Malmgren, Caroli ...
-
Delin, Jenny
-
Strid, Hans
-
Sjöberg, Mats
-
Bergemalm, Danie ...
-
Hjortswang, Henr ...
-
Halfvarson, Jona ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Gastroenterologi
- Artiklar i publikationen
-
Therapeutic Adva ...
- Av lärosätet
-
Örebro universitet
-
Karolinska Institutet
-
Linköpings universitet